Article: Prenatal management with digoxin and sotalol combination for fetal supraventricular tachycardia : Case report and review of literature

Introduction

Sustained tachyarrhythmias are the most clinically relevant rhythm disturbances in the fetus. Sustained fetal supraventricular tachycardia (SVT) with a heart rate of approximately 210 bpm may lead to congestive heart failure. [1],[2] There is no clear consensus regarding the best drug-treatment regimens for fetal SVT. Digoxin has been recommended as first-line therapy in cases of SVT with cardiac failure, but recent evidence suggests that its transplacental passage may be impaired in the presence of hydrops. [2],[3] Other agents such as flecainide and sotalol have been tried as first-line agents but with adverse events. [3],[4] We report a case of fetal supraventricular ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!